Paxlovid, a Pfizer’s coronavirus disease (COVID-19) pill, is seen manufactured in Ascoli, Italy, in this undated handout photo obtained by Reuters on November 16, 2021. Pfizer/Handout via REUTERS

Pfizer says COVID-19 pill near 90% effective in final analysis

NEW YORK, Dec 14 (Reuters) – Pfizer Inc. on Tuesday said final analysis of its antiviral COVID-19 pill still showed near 90% efficacy in preventing hospitalizations and deaths in high-risk patients,…

Read More

Purchase of Molnupiravir COVID-19 drug approved

Thailand’s cabinet on Tuesday approved the planned purchase of Merck’s Mulnupiravir COVID-19 anti-viral drug, with a budget of 500 million Baht set for 50,000 courses of the drug, amounting to…

Read More

Page 1 of 1

Login

Welcome! Login in to your account

Remember me Lost your password?

Lost Password